1-[2-(4-methylimidazol-1-yl)-4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;(E)-1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]pent-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]-2-(trifluoromethyl)phenyl]but-3-en-2-one

C122H105F3N14O8 — CID 162236723

IUPAC1-[2-(4-methylimidazol-1-yl)-4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;(E)-1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]pent-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]-2-(trifluoromethyl)phenyl]but-3-en-2-one
SMILESC/C=C/C(=O)Cc1ccc(C(=O)Cc2ccc(C)c(Cc3nccc(-c4cccnc4)n3)c2)cc1.C=CC(=O)Cc1ccc(C(=O)Cc2ccc(C)c(Cc3nccc(-c4cccnc4)n3)c2)cc1.C=CC(=O)Cc1ccc(C(=O)Cc2ccc(C)c(Cc3nccc(-c4cccnc4)n3)c2)cc1-n1cnc(C)c1.C=CC(=O)Cc1ccc(C(=O)Cc2ccc(C)c(Cc3nccc(-c4cccnc4)n3)c2)cc1C(F)(F)F
InChIInChI=1S/C33H29N5O2.C30H24F3N3O2.C30H27N3O2.C29H25N3O2/c1-4-29(39)16-25-9-10-26(17-31(25)38-20-23(3)36-21-38)32(40)15-24-8-7-22(2)28(14-24)18-33-35-13-11-30(37-33)27-6-5-12-34-19-27;1-3-25(37)15-21-8-9-22(16-26(21)30(31,32)33)28(38)14-20-7-6-19(2)24(13-20)17-29-35-12-10-27(36-29)23-5-4-11-34-18-23;1-3-5-27(34)17-22-9-11-24(12-10-22)29(35)18-23-8-7-21(2)26(16-23)19-30-32-15-13-28(33-30)25-6-4-14-31-20-25;1-3-26(33)16-21-8-10-23(11-9-21)28(34)17-22-7-6-20(2)25(15-22)18-29-31-14-12-27(32-29)24-5-4-13-30-19-24/h4-14,17,19-21H,1,15-16,18H2,2-3H3;3-13,16,18H,1,14-15,17H2,2H3;3-16,20H,17-19H2,1-2H3;3-15,19H,1,16-18H2,2H3/b;;5-3+;
InChIKeyZWDSSPJIHXMPIY-SXMYUENQSA-N
MW1952.27 g/mol
LogP22.55
Rot. Bonds37

About 1-[2-(4-methylimidazol-1-yl)-4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;(E)-1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]pent-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]-2-(trifluoromethyl)phenyl]but-3-en-2-one

1-[2-(4-methylimidazol-1-yl)-4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;(E)-1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]pent-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]-2-(trifluoromethyl)phenyl]but-3-en-2-one (PubChem CID 162236723) has the molecular formula C122H105F3N14O8 and a molecular weight of 1952.27 g/mol. Its IUPAC name is 1-[2-(4-methylimidazol-1-yl)-4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;(E)-1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]pent-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]-2-(trifluoromethyl)phenyl]but-3-en-2-one.

Molecular Properties

Compound Name1-[2-(4-methylimidazol-1-yl)-4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;(E)-1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]pent-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]-2-(trifluoromethyl)phenyl]but-3-en-2-one
PubChem CID162236723
Molecular FormulaC122H105F3N14O8
Molecular Weight1952.27 g/mol
Exact Mass1950.82
IUPAC Name1-[2-(4-methylimidazol-1-yl)-4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;(E)-1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]pent-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]-2-(trifluoromethyl)phenyl]but-3-en-2-one
SMILESC/C=C/C(=O)Cc1ccc(C(=O)Cc2ccc(C)c(Cc3nccc(-c4cccnc4)n3)c2)cc1.C=CC(=O)Cc1ccc(C(=O)Cc2ccc(C)c(Cc3nccc(-c4cccnc4)n3)c2)cc1.C=CC(=O)Cc1ccc(C(=O)Cc2ccc(C)c(Cc3nccc(-c4cccnc4)n3)c2)cc1-n1cnc(C)c1.C=CC(=O)Cc1ccc(C(=O)Cc2ccc(C)c(Cc3nccc(-c4cccnc4)n3)c2)cc1C(F)(F)F
InChIInChI=1S/C33H29N5O2.C30H24F3N3O2.C30H27N3O2.C29H25N3O2/c1-4-29(39)16-25-9-10-26(17-31(25)38-20-23(3)36-21-38)32(40)15-24-8-7-22(2)28(14-24)18-33-35-13-11-30(37-33)27-6-5-12-34-19-27;1-3-25(37)15-21-8-9-22(16-26(21)30(31,32)33)28(38)14-20-7-6-19(2)24(13-20)17-29-35-12-10-27(36-29)23-5-4-11-34-18-23;1-3-5-27(34)17-22-9-11-24(12-10-22)29(35)18-23-8-7-21(2)26(16-23)19-30-32-15-13-28(33-30)25-6-4-14-31-20-25;1-3-26(33)16-21-8-10-23(11-9-21)28(34)17-22-7-6-20(2)25(15-22)18-29-31-14-12-27(32-29)24-5-4-13-30-19-24/h4-14,17,19-21H,1,15-16,18H2,2-3H3;3-13,16,18H,1,14-15,17H2,2H3;3-16,20H,17-19H2,1-2H3;3-15,19H,1,16-18H2,2H3/b;;5-3+;
InChIKeyZWDSSPJIHXMPIY-SXMYUENQSA-N
XLogP22.55
TPSA309.06 Ų
H-Bond Donors
H-Bond Acceptors22
Rotatable Bonds37
Heavy Atoms147
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001952.27
LogP ≤ 522.55
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze 1-[2-(4-methylimidazol-1-yl)-4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;(E)-1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]pent-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]-2-(trifluoromethyl)phenyl]but-3-en-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-[2-(4-methylimidazol-1-yl)-4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;(E)-1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]pent-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]-2-(trifluoromethyl)phenyl]but-3-en-2-one?
The IUPAC name of 1-[2-(4-methylimidazol-1-yl)-4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;(E)-1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]pent-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]-2-(trifluoromethyl)phenyl]but-3-en-2-one (CID 162236723) is 1-[2-(4-methylimidazol-1-yl)-4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;(E)-1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]pent-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]-2-(trifluoromethyl)phenyl]but-3-en-2-one.
What is the SMILES notation for 1-[2-(4-methylimidazol-1-yl)-4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;(E)-1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]pent-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]-2-(trifluoromethyl)phenyl]but-3-en-2-one?
The canonical SMILES for 1-[2-(4-methylimidazol-1-yl)-4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;(E)-1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]pent-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]-2-(trifluoromethyl)phenyl]but-3-en-2-one is C/C=C/C(=O)Cc1ccc(C(=O)Cc2ccc(C)c(Cc3nccc(-c4cccnc4)n3)c2)cc1.C=CC(=O)Cc1ccc(C(=O)Cc2ccc(C)c(Cc3nccc(-c4cccnc4)n3)c2)cc1.C=CC(=O)Cc1ccc(C(=O)Cc2ccc(C)c(Cc3nccc(-c4cccnc4)n3)c2)cc1-n1cnc(C)c1.C=CC(=O)Cc1ccc(C(=O)Cc2ccc(C)c(Cc3nccc(-c4cccnc4)n3)c2)cc1C(F)(F)F.
What is the InChIKey of 1-[2-(4-methylimidazol-1-yl)-4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;(E)-1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]pent-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]-2-(trifluoromethyl)phenyl]but-3-en-2-one?
The InChIKey is ZWDSSPJIHXMPIY-SXMYUENQSA-N. The full InChI is InChI=1S/C33H29N5O2.C30H24F3N3O2.C30H27N3O2.C29H25N3O2/c1-4-29(39)16-25-9-10-26(17-31(25)38-20-23(3)36-21-38)32(40)15-24-8-7-22(2)28(14-24)18-33-35-13-11-30(37-33)27-6-5-12-34-19-27;1-3-25(37)15-21-8-9-22(16-26(21)30(31,32)33)28(38)14-20-7-6-19(2)24(13-20)17-29-35-12-10-27(36-29)23-5-4-11-34-18-23;1-3-5-27(34)17-22-9-11-24(12-10-22)29(35)18-23-8-7-21(2)26(16-23)19-30-32-15-13-28(33-30)25-6-4-14-31-20-25;1-3-26(33)16-21-8-10-23(11-9-21)28(34)17-22-7-6-20(2)25(15-22)18-29-31-14-12-27(32-29)24-5-4-13-30-19-24/h4-14,17,19-21H,1,15-16,18H2,2-3H3;3-13,16,18H,1,14-15,17H2,2H3;3-16,20H,17-19H2,1-2H3;3-15,19H,1,16-18H2,2H3/b;;5-3+;.
What are the key properties of 1-[2-(4-methylimidazol-1-yl)-4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;(E)-1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]pent-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]-2-(trifluoromethyl)phenyl]but-3-en-2-one?
1-[2-(4-methylimidazol-1-yl)-4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;(E)-1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]pent-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]-2-(trifluoromethyl)phenyl]but-3-en-2-one has a molecular weight of 1952.27 g/mol, XLogP of 22.55, 37 rotatable bonds, 0 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[2-(4-methylimidazol-1-yl)-4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]but-3-en-2-one;(E)-1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]phenyl]pent-3-en-2-one;1-[4-[2-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)methyl]phenyl]acetyl]-2-(trifluoromethyl)phenyl]but-3-en-2-one is sourced from PubChem (CID 162236723), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).